Institut Jules Bordet ( Site 0480)

Brussels, Bruxelles-Capitale, Region de 1000

0 studies enrolling now · 1 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) — Completed